US FDA asks advisory panel to examine dental amalgam safety
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration is asking its external experts to examine several scientific issues that may affect the regulation of dental amalgam, used for direct filling of carious lesions or structural defects in teeth.